The Addition of Fenofibrate to Ursodiol Improves Levels of Alkaline Phosphatase Among Patients with Primary Biliary Cholangitis That Do Not Respond to Ursodeoxycholic Acid Monotherapy

被引：0
|
作者：
Adekunle, Oreoluwa [1 ]
Gupta, Udita [1 ]
Chapman, Malcolm [1 ]
Richman, Joshua [1 ]
Gray, Meagan [1 ]
Ravi, Sujan [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1451
引用
收藏
页码：S1108 / S1108
页数：1
相关论文
共 50 条
  • [1] Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid
    Ding, Dawei
    Ren, Pengwei
    Guo, Guanya
    Liu, Yansheng
    Yang, Chunmei
    Zheng, Linhua
    Jia, Gui
    Deng, Juan
    Sun, Ruiqing
    Wang, Xiufang
    Zhou, Xinmin
    Shang, Yulong
    Han, Ying
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (09): : 692 - 701
  • [2] Fenofibrate Improves Alkaline Phosphatase in Primary Sclerosing Cholangitis
    Dejman, Adriana
    Clark, Virginia
    Martin, Paul
    Levy, Cynthia
    GASTROENTEROLOGY, 2013, 144 (05) : S1028 - S1029
  • [3] Alkaline phosphatase levels at 6 months as a predictor of response to ursodeoxycholic acid at 1 year in patients with primary biliary cholangitis
    Sendra, Carmen
    Silva-Ruiz, Maria del Pilar
    Mate, Carlota Jimeno
    Ruiz, Patricia Cordero
    Perez-Palacios, Domingo
    Romero, Gema
    Angulo-Mcgrath, Isabela
    Quiros-Rivero, Pablo
    Rosales-Zabal, Jose Miguel
    Sousa-Martin, Jose Manuel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S316 - S317
  • [4] Fenofibrate in Primary Biliary Cholangitis Patients With Inadequate Response to Ursodeoxycholic Acid (UDCA)
    Khaykis, Inessa
    Sherman, Alex
    Tobias, Hillel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S501 - S501
  • [5] Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid
    Ding, Dawei
    Guo, Guanya
    Liu, Yansheng
    Zheng, Linhua
    Jia, Gui
    Deng, Juan
    Sun, Ruiqing
    Wang, Xiufang
    Guo, Changcun
    Shang, Yulong
    Han, Ying
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (12) : 3487 - 3495
  • [6] Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol
    Ghonem, Nisanne S.
    Auclair, Adam M.
    Hemme, Christopher L.
    Gallucci, Gina M.
    de la Rosa Rodriguez, Randolph
    Boyer, James L.
    Assis, David N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1213 - 1223
  • [7] Alkaline Phosphatase Responsiveness to Ursodiol Therapy in Patients With Primary Biliary Cholangitis and Varying Degrees of Liver Fibrosis
    Mueller, Austin
    Garg, Noemi
    Jafri, Syed-Mohammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S911 - S911
  • [8] Ursodeoxycholic acid in patients with primary biliary cholangitis
    Numberger, Markus
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (01):
  • [9] RESPONSE TO URSODIOL THERAPY IN REDUCING ALKALINE PHOSPHATASE TO NORMAL LEVELS IN PRIMARY BILIARY CHOLANGITIS IN A DIVERSE COMMUNITY PRACTICE
    Mueller, Austin
    Jafri, Syed-Mohammed
    HEPATOLOGY, 2023, 78 : S2071 - S2072
  • [10] A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
    Li, Chunlei
    Zheng, Kunyu
    Chen, Yiran
    He, Chengmei
    Liu, Suying
    Yang, Yunjiao
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Li
    Zhang, Fengchun
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
12345